EMA grants orphan designation to Sanofi’s efdoralprin alfa for alpha-1 antitrypsin deficiency related emphysema: Paris Thursday, December 18, 2025, 13:00 Hrs [IST] Sanofi, an R& ...

Sanofi’s efdoralprin alfa earns orphan designation in the EU for alpha-1 antitrypsin deficiency related emphysema ...

Sanofi gains EMA Orphan Drug status for efdoralprin alfa, a phase II biologic for AATD-related emphysema with promising dosing data.

Paris: Sanofi has announced that the European Medicines Agency (EMA) has granted orphan designation to efdoralprin alfa ...

Century Health, a pioneer in applying AI to real-world clinical data to accelerate research, and Tessel Biosciences, a biotechnology company that combines human organoids and machine learning to model ...

Sanofi (EURONEXT: SAN) announced Wednesday that its investigational therapy, efdoralprin alfa, has received orphan drug ...

Ian Brown honours "brother" Mani at Manchester funeral, while Bobby Gillespie says bass icon will “will always live forever" ...

The government told Parliament there is no definitive evidence directly linking high AQI levels to lung diseases, though air ...

Delhi experienced severe smog on Monday, with the AQI reaching 498 - the city's most polluted day of the winter. Residents ...

The funeral has been held in Manchester for the legendary Stone Roses and Primal Scream bassist Gary ‘Mani’ Mounfield.

Discusses Year-End Late-Stage Pipeline Review With Focus on Clinical and Regulatory Developments December 16, 2025 11:15 AM ...

TSRA-196 is a potential one-time treatment to precisely correct the genetic mutation underlying AATD, with Investigational New Drug filing expected by the end of the year Tessera to receive $150 ...